These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3617176)

  • 1. Melarsoprol and reactive encephalopathy in Trypanosoma brucei rhodesiense.
    Arroz JO
    Trans R Soc Trop Med Hyg; 1987; 81(2):192. PubMed ID: 3617176
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
    Pialoux G; Kernbaum S; Vachon F
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications observed in the treatment of trypanosomiasis in the Congo].
    Ginoux PY; Bissadidi N; Frezil JL
    Med Trop (Mars); 1984; 44(4):351-5. PubMed ID: 6521632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
    Checkley AM; Pepin J; Gibson WC; Taylor MN; Jäger HR; Mabey DC
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):523-6. PubMed ID: 17270227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma brucei rhodesiense: effect of immunosuppression on the efficacy of melarsoprol treatment of infected mice.
    Frommel TO
    Exp Parasitol; 1988 Dec; 67(2):364-6. PubMed ID: 3191962
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy.
    Haller L; Adams H; Merouze F; Dago A
    Am J Trop Med Hyg; 1986 Jan; 35(1):94-9. PubMed ID: 3946740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness.
    Pepin J; Milord F; Guern C; Mpia B; Ethier L; Mansinsa D
    Lancet; 1989 Jun; 1(8649):1246-50. PubMed ID: 2566790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis.
    Pepin J; Milord F
    Trans R Soc Trop Med Hyg; 1991; 85(2):222-4. PubMed ID: 1887477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness.
    Pépin J; Milord F; Khonde AN; Niyonsenga T; Loko L; Mpia B; De Wals P
    Trans R Soc Trop Med Hyg; 1995; 89(1):92-7. PubMed ID: 7747321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of prednisolone as a routine adjunct to the treatment of T. rhodesiense.
    Foulkes JR
    J Trop Med Hyg; 1975 Apr; 78(4):72-4. PubMed ID: 1152100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of experimental trypanosomiasis caused by Trypanosoma brucei brucei in sheep: study of the minimum active dose of melarsoprol].
    Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):548-54. PubMed ID: 3197250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melarsoprol toxicity in the treatment of human African trypanosomiasis. Ten cases treated with dimercaprol.
    Scena MR
    Cent Afr J Med; 1988 Nov; 34(11):264-8. PubMed ID: 3252975
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol.
    ROBERTSON DH
    Trans R Soc Trop Med Hyg; 1963 May; 57():176-83. PubMed ID: 13974351
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. I. Reactions observed during treatment.
    ROBERTSON DH
    Trans R Soc Trop Med Hyg; 1963 Mar; 57():122-33. PubMed ID: 13974350
    [No Abstract]   [Full Text] [Related]  

  • 15. Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy.
    Adams JH; Haller L; Boa FY; Doua F; Dago A; Konian K
    Neuropathol Appl Neurobiol; 1986; 12(1):81-94. PubMed ID: 3703156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual course of west African trypanosomiasis in a Caucasian man.
    Grau Junyent JM; Rozman M; Corachán M; Estruch R; Urbano-Marquez A
    Trans R Soc Trop Med Hyg; 1987; 81(6):931-2. PubMed ID: 3503413
    [No Abstract]   [Full Text] [Related]  

  • 17. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
    Poltera AA; Hochmann A; Lambert PH
    Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative form of melarsoprol in sleeping sickness.
    Kennedy PG
    Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic, selenium, and African trypanosomiasis.
    Golden MH
    Lancet; 1992 Jun; 339(8806):1413. PubMed ID: 1350819
    [No Abstract]   [Full Text] [Related]  

  • 20. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.